Company Filing History:
2 out of 207 
1 out of 23 Years Active: 2000-2004
Title: The Innovative Contributions of Gregory G. Kubiak
Introduction: Gregory G. Kubiak, based in Wilmington, DE, is a notable inventor recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Kubiak has made strides in developing innovative processes and compounds that have implications for medical advancements.
Latest Patents: Kubiak's latest patents include groundbreaking work on stable non-hygroscopic crystalline forms of specific compounds, particularly the N-[N-[N-(4-(piperidin-4-yl)butanoyl)-N-ethylglycyl]aspartyl]-L-β-cyclohexyl alanine amide. This invention details the preparation methods and the potential applications of antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides. Additionally, he has developed a process for preparing N6-substituted adenosine derivatives, which focuses on the intermediates essential for this synthesis and the respective methods of their preparation.
Career Highlights: Gregory G. Kubiak has a rich professional background with notable positions in reputable companies such as Aventis Pharmaceuticals Inc. and Aventis Pharmaceuticals Products Inc. His work at these firms has positioned him at the forefront of pharmaceutical research and development.
Collaborations: Throughout his career, Kubiak has collaborated with talented professionals like Adam W. Sledeski and Matthew R. Powers. These partnerships have facilitated innovative research efforts and reinforced the importance of teamwork in the invention process.
Conclusion: Gregory G. Kubiak has made remarkable contributions to the pharmaceutical industry through his inventions and patents. His work in developing novel compounds and processes showcases his dedication to advancing medical science, making him an influential figure among contemporary inventors.